AstraZeneca vaccine: "When we have more knowledge, we will know what should be scary"

Audio 06:17

Ireland recommended suspending the use of the AstraZeneca vaccine as a “precaution”.

© Gent SHKULLAKU / AFP

By: Florent Guignard

8 mins

After the announcement of undesirable side effects in Denmark and Norway, almost eleven EU countries decided, as a precaution, to suspend vaccination with AstraZeneca.

The vaccine is said to have caused a blood clot in some patients.

Another controversy: delivery delays due to production difficulties.

In the second quarter, the laboratory will only be able to provide 70 million doses out of the 180 initially planned.

Decryption with Prof. Jean-Jacques Zambrowski, hospital doctor at Bichat hospital, professor of health policies and economics.

  • Vaccines

  • Health and medicine

  • European Union

  • Coronavirus